Acceptable presumptive evidence of immunity to measles, mumps, and rubella in children and adolescents^[1]

	Written documentation of age-appropriate vaccination*	Laboratory evidence of immunity^¶	Laboratory confirmation of disease
Measles	Number of doses of live measles virus-containing vaccine Age ≥12 month to <4 years: 1 dose Age ≥4 years: 2 doses	Positive serum measles IgG	Refer to UpToDate content on measles diagnosis
Mumps	Number of doses of live mumps-containing vaccine: Age ≥12 months to <4 years: 1 dose Age ≥4 years: 2 doses	Positive serum mumps IgG	Refer to UpToDate content on mumps diagnosis
Rubella	Age ≥12 months: 1 dose of live rubella-containing vaccine	Positive serum rubella IgG	Refer to UpToDate content on rubella diagnosis

This table summarizes acceptable presumptive evidence of measles, mumps, and rubella immunity for children and adolescents; however, state and local requirements may vary. Refer to UpToDate content on measles, mumps, and rubella immunization in children for additional details.

IgG: immunoglobulin G.
* The first dose of vaccine should be given at age ≥12 months; the second dose should be given ≥28 days after the first dose. Parent-or caregiver-reported doses are not valid without appropriate documentation.
¶ Equivocal results should be considered negative.

Reference:

McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62:1.

Graphic 134368 Version 1.0

خرید پکیج

Acceptable presumptive evidence of immunity to measles, mumps, and rubella in children and adolescents[1]

Acceptable presumptive evidence of immunity to measles, mumps, and rubella in children and adolescents^[1]